These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23800578)

  • 1. PEGylation of lysine residues reduces the pro-migratory activity of IGF-I.
    Sivaramakrishnan M; Kashyap AS; Amrein B; Saenger S; Meier S; Staudenmaier C; Upton Z; Metzger F
    Biochim Biophys Acta; 2013 Oct; 1830(10):4734-42. PubMed ID: 23800578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
    Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z
    Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration.
    Kashyap AS; Hollier BG; Manton KJ; Satyamoorthy K; Leavesley DI; Upton Z
    Endocrinology; 2011 Apr; 152(4):1388-401. PubMed ID: 21303956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration.
    Hyde C; Hollier B; Anderson A; Harkin D; Upton Z
    J Invest Dermatol; 2004 May; 122(5):1198-206. PubMed ID: 15140223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
    J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
    Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin.
    Kricker JA; Hyde CE; Van Lonkhuyzen DR; Hollier BG; Shooter GK; Leavesley DI; Herington AC; Upton Z
    Growth Factors; 2010 Oct; 28(5):359-69. PubMed ID: 20569097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA; Rosenzweig SA
    Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
    Yee D; Jackson JG; Kozelsky TW; Figueroa JA
    Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.